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ABSTRACT
The present work proposes a computational argumentation system
equipped with goal seeking to combine independently generated
recommendations for handling multimorbidity.
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1 INTRODUCTION
Multimorbidity is the presence of two or more medical conditions
[7, 9]. It poses challenges, namely in the use ofmultiple drugs, which
brings risks related to the interaction of the different drugs among
themselves (drug-drug interactions) and the effects their combina-
tion may have on the patient’s body (drug-disease interactions).
The few existing computational frameworks addressing this prob-
lem and aggregating recommendations produced from different
sources [4, 10–12], present limitations at the level of the number of
Computer-Interpretable Guidelines (CIGs) they are able to combine
and the dimensions of multimorbidity considered in their reason-
ing models. Regarding this last aspect, these works do not include
the representation of human-centric aspects of decision-making
in multimorbidity, namely those that are related to preferences ex-
pressed by the physicians and patients regarding the treatment.To
answer these challenges, we present a structured argumentation
framework called ASPIC-G and provide the following contribu-
tions in this paper: (i) representation and reasoning mechanisms
for aggregating CIG recommendations from multiple agents; (ii) an
argumentation system called ASPIC-G that provides an explicit and
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explanatory representation of the different conflicts in a decision-
making situation; (iii) an extension to the ASPIC+ argumentation
system by including goals in the argumentation process.
2 CASE EXAMPLE
The case example to be used throughout the paper [7, 9], is the
following.
Example 2.1. Patient A is a 69-year-old man with a 5-year history
of type 2 diabetes. Upon consultation and the completion of medical
exams, it was possible to conclude that the patient has uncontrolled
type 2 diabetes, obesity, and severe chronic kidney disease. The
latter is a common condition characterized by the progressive loss
of kidney function over a period of months or years.
The example describes the current state of a patient that has three
health conditions. The case is run in a system with CIG agents that
handle each one of these conditions separately, with the following
recommendations and explanations.
CIG Agent 1 (for obesity): Define weight loss (w_loss) as a
therapy goal. In order to reduce weight, the patient should practice
diet and exercise (diet_ex).
CIG Agent 2 (for diabetes): Define blood glucose lowering
(gluc_low) as a therapy goal. Sulfonylurea (sulf ) ormeglitinide (meg)
can reduce blood glucose elevations, but they are also associated
withweight gain (w_gain). Metformin (met) can lower blood glucose
by reducing hepatic glucose. The patient should only take one of
the drugs.
CIGAgent 3 (for kidney disease):Define delay kidney disease
(delay_kid) as a therapy goal. To that effect, the patient is advised
to take angiotensin converting enzyme inhibitors (ang_conv_enz),
as they have been found to slow the progression of chronic kidney
disease to kidney failure. In severe chronic kidney disease, the use of
metformin should be avoided as the drug generates large amounts
of lactic acid, which may cause the kidneys to overwork ant thus
deteriorate faster (acc_kid).
In essence, following the three CIG Agents separately would
generate conflicts at the level of treatment effects/ treatment goals.
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In real practice, this type of case is handled by establishing a pri-
ority of therapy goals, and thus addressing the goals by order of
importance. This reflects the emerging trend in health care of col-
laborative goal setting [1, 8], with the involvement of patients in
their own treatment process.
3 THE ASPIC-G ARGUMENTATION SYSTEM
We define the ASPIC-G argumentation system as follows.
Definition 3.1. An argumentation theory in ASPIC-G is a tuple
⟨L,R,n,G,6⟩, where:
• L is a logical language closed under negation (¬).
• R = Rs ∪ Rd is a set of strict (Rs ) and defeasible (Rd ) rules
of the form ϕ1, ...,ϕn → ϕ and ϕ1, ...,ϕn ⇒ ϕ respectively,
where n ≥ 0 and ϕi ,ϕ ∈ L.
• n is a partial function such that n : R → L.
• G ⊆ L is a set of goals that the arguments will try to fulfil
such that ∀ θ ∈ G, there exists a rule ϕ1, ...,ϕn → ϕ in Rs
or ϕ1, ...,ϕn ⇒ ϕ in Rd such that ϕ = θ .
• 6 is a total relation transitive and reflexive over G which
represents preference of the goals, with a < b iff a 6 b and
b 
 a.
The construction of arguments follows the structure defined in
ASPIC+ [5]. Attacks are also defined as in ASPIC+, with the excep-
tion that only rebuttal and undercutting are allowed. Undermining
attacks as a special case of rebuttal. The selection of arguments
follows Dung’s abstract argumentation framework [3]. Given the
context in which ASPIC-G is applied, it is of interest to produce
the preferred extensions, and thus maximal, self-defended sets of
arguments. When using ASPIC-G for decision-making, the aim
is to fulfil the preferred goals. Similar goal-driven mechanisms in
argumentation have been proposed in [2] and [6]. As such, each
preferred extension is lifted to a goal extension, containing the goals
it fulfils. A goal extension ordering GEA EGE GEB denotes that
GEA is less preferred than GEB . This ordering is determined by
several factors. However, the underlying principle is that the argu-
mentation system will always try to fulfil the goals by their order of
importance. As such, assuming a goal preference order a < b < c ,
the priority will always be fulfilling goal c . Therefore, if we have
goal extensions {c} and {a,b}, then {a,b} EGE {c}. Not fulfilling
any goals is the least preferred alternative. Notice that every set
is equally preferred to itself. The preferred set is the one with the
most preferred goal, with respect to the maximal elements of each
set. The ordering EGE is placed over their respective preferred
extensions to determine which hold the most suitable solutions for
the argumentation.
4 MULTIMORBIDITY IN ASPIC-G
Assuming the goals given in Example 2.1, G = {w_loss,дluc_low,
delay_kid}, and goal preference order, w_loss < delay_kid <
дluc_low , as well as the rules derived from the example, it is possible
to build the following arguments:
A1 :⇒ diet_ex .
A2 : A1 ⇒ w_loss .
B1 :⇒ sul f .
B2 : B1 → дluc_low .
B′2 : B1 → ¬met .
B′′2 : B1 → ¬meд.
B′′′2 : B1 → w_дain.
B3 : B′′′2 → ¬r1.
C1 :⇒meд.
C2 : C1 → дluc_low .
C ′2 : C1 → ¬met .
C ′′2 : C1 → ¬sul f .
C ′′′2 : C1 → w_дain.
C3 : C ′′′2 → ¬r1.
D1 :⇒met .
D2 : D1 → дluc_low .
D ′2 : D1 → ¬meд.
D ′′2 : D1 → ¬sul f .
E1 :⇒ anд_conv_enz.
E ′1 :→ chron_kid_dis .
D ′′′2 : E
′
1,D1 → acc_kid .
D3 : D ′′′2 → ¬delay_kid .
D4 : D3 →
¬anд_conv_enz.
E2 : E1,E ′1 → delay_kid .
E3 : E2 → ¬acc_kid .
E4 : E ′1,E3 → ¬met .
G1 : w_loss .
G2 : дluc_low .
G3 : delay_kid .
To reduce the complexity of the problem, we simplify the derived
arguments by merging themwith respect to their most relevant rule.
Since, in this case, the elements of interest consist of treatments
to apply to the patient, the defeasible rules denoting them become
the most relevant rules. Following this principle, we obtain the
following arguments: argument A1 conveys that the patient should
do diet and exercise; argument A2 conveys that diet and exercise
lead to weight loss; argument B conveys that the patient should
take sulfonylurea; argument C conveys that the patient should
take meglitinide; argument D conveys that the patient should take
metformin; argument E conveys that the patient should take an-
giotensin converting enzyme. Based on this simplification step, we
are able to calculate the preferred extensions (Pi ) of the simpli-
fied argumentation theory. We also calculate their respective goal
extensions (GEPi ). The results are the following:
• P1 = {A1,B,E}, GEP1 = {G2,G3}
• P2 = {A1,C,E}, GEP2 = {G2,G3}
• P3 = {A1,A2,D}, GEP3 = {G1,G2}
Sowe have three possible solutions for the argumentation theory:
S1, S2, and S3. Each one fulfilling their respective goals. Considering
the already established goal order of G1 < G3 < G2, we calculate
the goal extension ordering EGE and then use it to calculate, the
preferred extension ordering EP :
• GEP3 EGE GEP1 , GEP2
• P3 EP P1, P2
Extensions P1 and P2 both fulfil the two top goals and are the
top solutions to this argumentation theory in multimorbidity. This
means that in Example 1, the patient should practice diet and exer-
cise, take either sulfonylurea or meglitinide for his diabetes problem
in order to reduce blood glucose, and take angiotensin converting
enzyme to delay the progression of kidney disease. This is the con-
sistent treatment. The ASPIC-G argumentation system ensures that
the most important goals in the treatment process are achieved.
5 CONCLUSIONS
The purpose of ASPIC-G is to model discussions driven by goals,
where it is not only important to have explanatory arguments in
favour or against a position, but also to know where argumentation
paths lead to. This is done by combining the recommendations of
agents and deriving conflicts that arise from them.
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